Mubadala to invest in manufacturer of opthalmic lenses

Mubadala Investment Company today announced that it will invest in Rodenstock Group, the leading manufacturer of premium ophthalmic lenses, as a minority investor alongside Funds advised by Apax (Apax Funds). Founded in 1877, Rodenstock has been a global leader in prescription lenses for over 140 years, with a strong track record of innovative product development and market leading technologies. Headquartered in Munich, Germany, Rodenstock employs around 4,900 people worldwide and is represented by sales subsidiaries and distribution partners in more than 85 countries.

Mubadala Investment Company to invest in Rodenstock Group

Rodenstock has a strong portfolio of innovative technologies; its patented DNEye Pro technology is at the heart of its business strategy and enabled Rodenstock to become the first company to measure the individual shape and size of each eye using thousands of data points. The technology allows the company to produce individualized eyeglass lenses, called Biometric Intelligent Glasses (B.I.G. VISION ). The company’s portfolio also includes eyewear under the Rodenstock and Porsche Design brands. The transaction is subject to applicable regulatory approvals and is expected to close in the middle of 2021.

Previous Post Next Post